MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
BioLife Solutions Financial Ratios 2011-2026 | BLFS
Annual Financial Ratios BioLife Solutions
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-56.4 | -10.9 | -6.7 | -129.0 | 522.2 | -171.9 | 65.4 | -28.6 | -3.3 | -0.0 | -5.7 | -36.4 | -10.5 | -2.1 |
P/S |
13.8 | 9.7 | 12.3 | 9.6 | 21.5 | 10.4 | 10.8 | 6.5 | 2.8 | 0.0 | 3.0 | 4.4 | 3.1 | 1.5 |
EPS |
-0.4 | -1.6 | -3.3 | -0.2 | 0.1 | -0.1 | -1.6 | -0.2 | -0.5 | -0.3 | -0.3 | -0.2 | -0.0 | -0.0 |
EV (Enterprise Value) |
1.09 B | 786 M | 1 B | 1.16 B | 975 M | 328 M | 185 M | 67.4 M | 26.1 M | 2.16 B | 18.1 M | 55.9 M | 32.9 M | 17 M |
EBITDA per Share |
-0.04 | -0.37 | 0.02 | -0.79 | -0.15 | 0.095 | 0.246 | -0.0541 | -0.355 | -291 | -0.275 | -0.00764 | -0.155 | -0.224 |
EV/EBITDA |
-38.3 | -3160.5 | 150.6 | 45.7 | -91.1 | -5.4 | 0.8 | -5.5 | -1303.6 | -36.0 | -3.7 | |||
PEG |
0.14 | 0.03 | 0.06 | 1.21 | -2.47 | -1.07 | 0.35 | -0.47 | 0.06 | 0.0 | 0.14 | -1.7 | -0.31 | 6.42 |
P/B |
3.3 | 2.2 | 2.6 | 2.4 | 5.0 | 6.6 | 4.9 | 7.1 | 7.2 | 0.0 | 1.3 | -3.0 | -1.4 | -0.4 |
P/CF |
134.9 | -59.1 | -110.5 | -250.2 | 155.8 | 529.6 | 115.5 | 156.1 | -4.1 | -0.0 | -4.9 | -435.3 | -58.7 | -3.9 |
ROE % |
-5.78 | -20.14 | -38.39 | -1.86 | 0.97 | -3.81 | 7.57 | -24.92 | -217.16 | -27.96 | -23.09 | 8.17 | 13.29 | 17.50 |
ROA % |
-5.05 | -16.48 | -31.05 | -1.61 | 0.84 | -1.79 | 7.18 | -20.71 | -86.74 | -20.54 | -20.02 | -32.33 | -52.36 | -117.73 |
ROCE % |
-2.04 | -6.94 | -1.63 | -7.35 | -3.05 | 0.90 | 8.41 | -9.93 | -71.41 | -22.29 | -21.17 | -16.54 | -52.22 | -111.72 |
Current Ratio |
7.9 | 5.5 | 5.2 | 7.3 | 7.9 | 3.1 | 19.4 | 6.6 | 4.1 | 9.6 | 9.6 | 1.2 | 1.2 | 2.0 |
DSO |
37.9 | 100.6 | 136.8 | 47.8 | 50.7 | 71.3 | 56.3 | 33.8 | 53.0 | 53.2 | 53.2 | 41.2 | 38.7 | 72.4 |
DIO |
- | - | - | - | - | 457.2 | 206.0 | 157.7 | 186.1 | 111.7 | 111.7 | 29.6 | 71.1 | 136.2 |
DPO |
- | - | - | - | - | 130.0 | 42.3 | 59.0 | 75.2 | 54.9 | 54.9 | 61.0 | 93.4 | 108.5 |
Operating Cycle |
37.9 | 100.7 | 136.8 | 47.8 | 50.7 | 528.4 | 262.3 | 191.5 | 239.0 | 164.8 | 164.8 | 70.8 | 109.8 | 208.6 |
Cash Conversion Cycle |
37.9 | 100.7 | 136.8 | 47.8 | 50.7 | 398.5 | 220.0 | 132.5 | 163.8 | 109.9 | 109.9 | 9.8 | 16.4 | 100.1 |
All numbers in USD currency
Quarterly Financial Ratios BioLife Solutions
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.01 | -0.33 | -0.01 | - | -0.04 | -0.45 | -0.22 | - | -0.67 | -0.23 | -0.32 | - | -0.24 | -1.72 | -0.18 | - | - | 0.2 | -0.03 | - | -0.04 | -0.7 | 0.87 | - | 0.42 | 0.18 | -1.03 | - | -1.42 | -1.74 | 0.22 | - | -0.03 | -0.06 | -0.07 | - | -0.08 | -0.11 | -0.1 | - | -0.09 | -0.08 | -0.09 | - | -0.07 | -0.07 | -0.1 | - | -0.06 | -0.06 | - | - | -0.01 | -0.01 | - | - | -0.01 | -0.01 | -0.01 |
EBITDA per Share |
- | -0.34 | -0.01 | - | - | -0.02 | -0.04 | - | -0.33 | -0.23 | -0.28 | - | -0.25 | -1.79 | -0.15 | - | -0.2 | -0.07 | -0.01 | - | 0.01 | 0.04 | 0.04 | - | -0.02 | 0.05 | 0.04 | - | 0.08 | 0.1 | 0.02 | - | 0.02 | -0.01 | -0.03 | - | -0.07 | -0.11 | -0.11 | - | -0.09 | -0.08 | -0.09 | - | -0.06 | -0.06 | -0.06 | - | 0.01 | 0.01 | 0.05 | - | - | - | - | - | - | - | -0.01 |
ROE % |
-5.04 | -5.74 | -7.62 | -10.03 | -18.81 | -27.06 | -23.51 | -15.50 | -18.05 | -11.82 | -26.72 | -21.90 | -21.88 | -19.32 | 0.21 | 1.22 | 0.67 | 0.10 | -9.62 | 2.34 | 25.97 | 50.15 | 67.92 | -10.68 | -67.38 | -147.71 | -218.55 | -106.47 | -109.62 | -56.08 | -2.63 | -19.39 | -35.12 | -47.69 | -59.95 | -52.09 | -64.65 | -61.48 | -53.29 | -36.37 | -43.68 | -38.42 | -34.22 | -19.53 | -17.19 | -7.55 | 2.06 | 4.52 | 7.34 | 7.82 | 9.69 | 9.19 | 13.48 | 14.94 | 14.85 | 13.82 | 4.28 | 3.91 | 5.64 |
ROA % |
-4.49 | -5.10 | -6.53 | -8.52 | -15.60 | -22.24 | -19.07 | -12.51 | -14.63 | -9.65 | -22.78 | -18.96 | -18.95 | -16.82 | 0.18 | 1.06 | 0.58 | 0.08 | -8.41 | 2.04 | 13.11 | 24.65 | 36.21 | -5.00 | -58.81 | -123.68 | -186.21 | -101.04 | -103.66 | -52.48 | -0.86 | -16.12 | -28.34 | -37.94 | -48.72 | -44.81 | -53.45 | -49.86 | -40.80 | -25.02 | -30.38 | -27.11 | -24.57 | -14.34 | -23.58 | -27.46 | -30.39 | -17.88 | -28.99 | -30.86 | -38.18 | -36.22 | -65.02 | -82.71 | -93.24 | -92.99 | -28.80 | -26.27 | -37.91 |
ROCE % |
-5.29 | -5.40 | -1.01 | -1.52 | -6.18 | -10.72 | -13.33 | -11.48 | -14.38 | -12.61 | -28.29 | -23.27 | -25.55 | -24.93 | -7.24 | -3.76 | -4.36 | -2.69 | -1.66 | -0.41 | -2.18 | -3.35 | -1.65 | 1.24 | 4.01 | 8.56 | 9.82 | 6.07 | 5.75 | 2.66 | -3.70 | -8.30 | -26.77 | -44.91 | -64.89 | -61.88 | -77.12 | -73.89 | -64.11 | -42.46 | -49.87 | -42.04 | -35.98 | -18.06 | -17.23 | -8.99 | -0.84 | 0.00 | 1.20 | 1.56 | 3.39 | 5.08 | 7.63 | 8.99 | 8.86 | 8.94 | 2.55 | 2.33 | 4.06 |
Current Ratio |
10.2 | 9.7 | 9.3 | 7.9 | 6.8 | 7.0 | 5.9 | 5.5 | 5.2 | 5.3 | 5.0 | 5.2 | 5.9 | 7.7 | 8.0 | 7.5 | 8.0 | 7.6 | 7.7 | 7.9 | 7.9 | 7.9 | 7.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.5 | 19.6 | 19.6 | 19.6 | 5.9 | 5.9 | 5.9 | 5.9 | 1.7 | 1.7 | 1.7 | 1.7 | 4.9 | 4.9 | 4.9 | 4.9 | 7.5 | 7.5 | 7.5 | 7.5 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 |
DSO |
34.0 | 34.5 | 34.9 | - | 76.8 | 84.8 | 87.9 | - | 99.5 | 89.3 | 77.8 | - | 71.3 | 62.5 | 59.8 | - | 55.8 | 46.4 | 50.6 | - | 64.8 | 73.6 | 50.1 | - | -1676.0 | -2247.6 | -1650.0 | - | -6461.8 | -1569.8 | -1288.3 | - | -428.0 | -358.3 | -440.6 | - | - | - | - | - | 17931.4 | 15468.4 | 10141.5 | - | 10743.4 | 18214.1 | - | - | - | - | 34.0 | - | 32.6 | 49.9 | 62.6 | - | 69.8 | 80.2 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 219.4 | 235.3 | 225.5 | - | 478.1 | 508.7 | 401.1 | - | 199.4 | 208.3 | 179.2 | - | 153.8 | 176.1 | 177.1 | - | 174.2 | 183.8 | 212.6 | - | 254.2 | 246.9 | 206.7 | - | 134.5 | 132.1 | 54.4 | - | 30.0 | 25.6 | 47.5 | - | 55.1 | 93.3 | 153.2 | - | 133.6 | 159.8 | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 69.4 | 74.5 | 67.8 | - | 135.9 | 144.6 | 106.3 | - | 40.9 | 42.8 | 47.2 | - | 57.5 | 65.9 | 68.9 | - | 70.4 | 74.3 | 103.0 | - | 142.6 | 138.5 | 111.0 | - | 66.1 | 65.0 | 52.7 | - | 61.7 | 52.7 | 76.3 | - | 72.5 | 122.6 | 166.8 | - | 106.5 | 127.3 | - |
Operating Cycle |
34.0 | 34.5 | 34.9 | - | 76.8 | 84.8 | 87.9 | - | 99.5 | 89.3 | 77.8 | - | 71.3 | 62.5 | 59.8 | - | 55.8 | 46.4 | 50.6 | - | 284.1 | 309.0 | 275.6 | - | -1197.9 | -1738.9 | -1248.8 | - | -6262.4 | -1361.5 | -1109.1 | - | -274.2 | -182.2 | -263.4 | - | 174.2 | 183.8 | 212.6 | - | 18185.6 | 15715.2 | 10348.1 | - | 10877.9 | 18346.2 | 54.4 | - | 30.0 | 25.6 | 81.5 | - | 87.7 | 143.2 | 215.8 | - | 203.4 | 240.0 | - |
Cash Conversion Cycle |
34.0 | 34.5 | 34.9 | - | 76.8 | 84.8 | 87.9 | - | 99.5 | 89.3 | 77.8 | - | 71.3 | 62.5 | 59.8 | - | 55.8 | 46.4 | 50.6 | - | 214.7 | 234.5 | 207.7 | - | -1333.8 | -1883.5 | -1355.2 | - | -6303.3 | -1404.2 | -1156.3 | - | -331.8 | -248.1 | -332.3 | - | 103.8 | 109.5 | 109.6 | - | 18043.0 | 15576.7 | 10237.1 | - | 10811.8 | 18281.2 | 1.7 | - | -31.8 | -27.1 | 5.2 | - | 15.2 | 20.6 | 49.0 | - | 96.9 | 112.7 | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company BioLife Solutions, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Medical instruments industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
- | - | $ 810 M |  USA |
 |
Becton, Dickinson and Company
BDX
|
$ 154.51 | -1.17 % | $ 44.4 B | USA |
 |
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | USA |
 |
Repligen Corporation
RGEN
|
$ 117.78 | -0.46 % | $ 6.56 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
$ 9.4 | -11.74 % | $ 22.8 M | USA |
 |
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | USA |
 |
Haemonetics Corporation
HAE
|
$ 56.83 | 1.05 % | $ 2.86 B | USA |
 |
ICU Medical
ICUI
|
$ 123.31 | -1.53 % | $ 3.04 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | USA |
 |
Intuitive Surgical
ISRG
|
$ 452.07 | -2.67 % | $ 161 B | USA |
 |
Harvard Bioscience
HBIO
|
$ 5.2 | 2.16 % | $ 231 M | USA |
 |
Isoray
ISR
|
- | 0.03 % | $ 108 M | USA |
 |
AngioDynamics
ANGO
|
$ 10.31 | -13.65 % | $ 421 M | USA |
 |
Repro Med Systems
KRMD
|
$ 4.32 | 1.17 % | $ 200 M | USA |
 |
AtriCure
ATRC
|
$ 29.07 | 2.68 % | $ 1.39 B | USA |
 |
Pulse Biosciences
PLSE
|
$ 23.0 | -0.13 % | $ 1.55 B | USA |
 |
InfuSystem Holdings
INFU
|
$ 9.29 | -0.11 % | $ 192 M | USA |
 |
Masimo Corporation
MASI
|
$ 178.59 | 0.33 % | $ 9.52 B | USA |
 |
iRhythm Technologies
IRTC
|
$ 116.8 | -1.2 % | $ 3.74 B | USA |
 |
Merit Medical Systems
MMSI
|
$ 67.7 | -0.78 % | $ 4 B | USA |
 |
electroCore
ECOR
|
$ 6.8 | 3.03 % | $ 57.7 K | USA |
 |
STERIS plc
STE
|
$ 218.71 | -0.56 % | $ 21.6 B | USA |
 |
Teleflex Incorporated
TFX
|
$ 117.81 | -0.52 % | $ 5.26 B | USA |
 |
Utah Medical Products
UTMD
|
$ 63.12 | 0.4 % | $ 205 M | USA |
 |
OraSure Technologies
OSUR
|
$ 3.08 | 0.98 % | $ 226 M | USA |
 |
West Pharmaceutical Services
WST
|
$ 254.8 | 0.82 % | $ 18.4 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
$ 11.63 | -0.26 % | $ 2.32 B | USA |
 |
Glaukos Corporation
GKOS
|
$ 112.77 | 0.12 % | $ 5.46 B | USA |
 |
ResMed
RMD
|
$ 224.09 | 0.56 % | $ 32.7 B | USA |
 |
Predictive Oncology
POAI
|
- | - | $ 31.1 M | USA |
 |
Baxter International
BAX
|
$ 16.68 | -0.6 % | $ 8.56 B | USA |
 |
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | USA |
 |
STAAR Surgical Company
STAA
|
$ 20.21 | 4.55 % | $ 1 B | USA |
 |
Stereotaxis
STXS
|
$ 1.87 | 1.08 % | $ 170 M | USA |
 |
The Cooper Companies
COO
|
$ 70.17 | -1.76 % | $ 14 B | USA |
 |
LeMaitre Vascular
LMAT
|
$ 108.49 | -0.24 % | $ 2.46 B | USA |
 |
Microbot Medical
MBOT
|
$ 2.4 | 1.27 % | $ 110 M |  Israel |
 |
Nephros
NEPH
|
$ 2.87 | -2.21 % | $ 29.8 M | USA |
 |
Envista Holdings Corporation
NVST
|
$ 25.81 | -0.35 % | $ 4.34 B | USA |
 |
Milestone Scientific
MLSS
|
$ 0.28 | -4.86 % | $ 23 M | USA |
 |
Alcon
ALC
|
$ 74.56 | -1.26 % | $ 40.4 B |  Schweiz |
 |
Pro-Dex
PDEX
|
$ 51.67 | 1.33 % | $ 170 M | USA |
 |
Retractable Technologies
RVP
|
$ 0.69 | 2.99 % | $ 20.7 M | USA |